Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15059882 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum
Condition: Non-Metastatic Adenocarcinoma of the Rectum
Interventions: Procedure: Radiation Therapy;   Drug: Capecitabine;   Drug: AZD6244

Indicates status has not been verified in more than two years